secwatch / observer
8-K filed April 8, 2022, 7:59 PM ET ticker KMPR CIK 0000860748
leadership confidence high sentiment neutral materiality 0.45

Life & Health Division President Erich Sternberg resigns; Tim Stonehocker succeeds

KEMPER Corp

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Erich Sternberg

Executive Vice President
KMPR · KEMPER Corp
Effective
2022-04-04
Successor
Tim Stonehocker
Filed
April 8, 2022, 7:59 PM ET
Mr. Stonehocker replaces Erich Sternberg, Executive Vice President, who resigned his position with the Company on April 4, 2022 to pursue other career opportunities.
Appointed

Tim Stonehocker

President of the Company’s Life & Health Division
KMPR · KEMPER Corp
Effective
2022-04-08
Filed
April 8, 2022, 7:59 PM ET
Effective immediately, Tim Stonehocker, Senior Vice President, will assume the role of President of the Company’s Life & Health Division.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Erich Sternberg resigned as Executive Vice President at KEMPER Corp.

Action
resigned
Role
Executive Vice President
Exact text from the filing
Mr. Stonehocker replaces Erich Sternberg, Executive Vice President, who resigned his position with the Company on April 4, 2022 to pursue other career opportunities.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Tim Stonehocker was appointed as President of the Company’s Life & Health Division at KEMPER Corp.

Action
appointed
Role
President of the Company’s Life & Health Division
Exact text from the filing
Effective immediately, Tim Stonehocker, Senior Vice President, will assume the role of President of the Company’s Life & Health Division.
View on SEC.gov

KEMPER Corp filing history →

Source: SEC EDGAR
accession 0000860748-22-000053
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.